• OSMI-1: O-GlcNAc Transferase Inhibitor Guide

  2026-09-10

  OSMI-1 is a cell-permeable O-GlcNAc transferase inhibitor with a reported biochemical IC50 of 2.7 μM. It reduces protein O-GlcNAcylation and provides a research tool for testing OGT-dependent mechanisms, including pathways relevant to trophoblast ferroptosis.

• DiR (DiIC 18 (7)) for EV Tracking Assays

  2026-09-10

  DiR (DiIC 18 (7)) is more than a membrane stain: it can help design spatial and temporal assays for extracellular vesicle biodistribution. This article explains how to use its near-infrared signal while avoiding common errors in interpreting membrane-associated fluorescence as proof of intact vesicle delivery.

• PD0325901 Workflows for MEK Signaling Research

  2026-09-09

  PD0325901 provides a controllable way to connect MEK inhibition with P-ERK loss, cell-cycle remodeling, apoptosis, and xenograft response. This workflow also shows how findings on O-GlcNAcylation and galectin-3 can improve assay selection without overstating cross-domain evidence.

• DiR (DiIC 18 (7)) for Reliable Cell Tracking

  2026-09-09

  Learn how DiR (DiIC 18 (7)) and SKU B8806 can strengthen membrane tracking, live-cell imaging, and orthogonal interpretation of viability or cytotoxicity assays. This scenario-based guide covers compatibility, formulation, controls, data interpretation, and practical vendor selection.

• CLA, PPARγ/NFκB, and NEC Barrier Protection

  2026-09-08

  This 2024 Journal of Functional Foods study combined fecal metabolomics, neonatal rat experiments, intestinal cell assays, and RNA sequencing to investigate conjugated linoleic acid (CLA) in necrotizing enterocolitis (NEC). The findings connect reduced linoleic acid compounds with NEC severity and suggest that CLA protects the immature intestine by enhancing PPARγ signaling, restraining NFκB activity, reducing inflammation, and preserving barrier-related cellular homeostasis.

• AhR–RBX1/HSF1 Signaling in Acute Pancreatitis

  2026-09-08

  Fang and colleagues identify aryl hydrocarbon receptor signaling as a regulator of pancreatic tight-junction injury in experimental acute pancreatitis. Their data connect AhR with RBX1-dependent control of HSF1 and macrophage polarization, while pharmacologic disruption with triptolide weakens the protective phenotype.

• Circadian Glycogen Biology: From Mice to Translation

  2026-09-07

  Circadian exercise research is revealing that performance adaptation cannot be explained by bulk glycogen alone. This thought-leadership article shows how a glucose-derived colorimetric readout can strengthen experimental design, clarify metabolic interpretation, and support translational studies from exercise physiology to glycogen storage disease research.

• DiR: From Membrane Signal to EV Fate

  2026-09-07

  DiR (DiIC 18 (7)) is more than a membrane labeling dye: it can help distinguish extracellular vesicle biodistribution from true cargo delivery. This guide presents an assay-centered strategy for live imaging, fixed tissue analysis, and testing MPS escape claims.

• Letrozole: Translational Strategy Beyond Estrogen Suppressio

  2026-09-05

  Letrozole is more than a potent non-steroidal aromatase inhibitor: it is a translational tool for testing how estrogen availability, receptor signaling, endocrine feedback, and tissue context shape experimental outcomes. This article presents a mechanistic framework for breast cancer research, model validation, biomarker integration, and disciplined interpretation beyond the conventional product-page narrative.

• Trypsin-Responsive Nanomedicine for Acute Pancreatitis

  2026-09-04

  Wang and colleagues developed a biomimetic mesoporous organosilica nanoparticle that targets injured pancreatic acinar cells and releases BAPTA-AM in response to prematurely activated trypsin. In a mouse model, this upstream calcium-control strategy reduced pancreatic injury, improved biochemical outcomes, and increased survival, while also illustrating how disease-specific triggers can refine nanomedicine design.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody for MAVS Assays

  2026-09-04

  Build sensitive MAVS and antiviral signaling assays with a far-red Cy5 conjugated secondary antibody designed for rabbit primary antibodies. This practical guide covers immunofluorescence, western blotting, flow cytometry, storage, controls, and troubleshooting for translating ASB3–MAVS biology into reproducible fluorescence data.

• ARCA Cy5 EGFP mRNA (5-moUTP): Delivery Guide

  2026-09-03

  ARCA Cy5 EGFP mRNA (5-moUTP) combines a Cy5-labeled delivery readout with EGFP translation reporting in 5-methoxyuridine modified mRNA. Its defined length, buffer, concentration, cap structure, and storage conditions support reproducible mRNA localization and translation efficiency assay design.

• EZ Cap Cy5 Firefly Luciferase mRNA Guide

  2026-09-03

  Learn how EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), SKU R1010, separates mRNA uptake from productive translation in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay compatibility, transfection optimization, data interpretation, storage, and vendor selection using product specifications and peer-reviewed delivery research.

• FOXO3–YAP Dual Metabolic Targeting in HCC

  2026-09-02

  This study identifies FOXO3 as a tumor-suppressive regulator that simultaneously restrains glycolysis and glutaminolysis in hepatocellular carcinoma through direct repression of YAP. Its combination of promoter-level mechanism, metabolic assays, in vivo validation, and patient-derived organoids supports the FOXO3/YAP axis as a potential strategy for overcoming metabolic plasticity in HCC.

• Capecitabine in Patient-Derived Assembloids

  2026-09-02

  Learn how Capecitabine can be evaluated in matched tumor organoid–stroma systems to distinguish tumor-selective activation from microenvironment-driven resistance. This practical workflow combines prodrug handling, paired viability and mechanism assays, and troubleshooting strategies for translational oncology.

8297 records 1/554 page Next 12345 下5页 Last page